Embracing pharmacists’ roles in health-care delivery

Embracing pharmacists’ roles in health-care delivery

The universal shortage of qualified health workers remains a persistent challenge for health-care systems. As per the WHO European Framework for Action on Health and Care Workforce1 a solution lies in redefining and re-distributing tasks across different health-care providers to keep pace with patient needs, advances in professional education and new technologies.2 In this context, the contribution of pharmacists to achieving health system priorities becomes critical. Pharmacists, particularly those working in community settings, are essential yet often overlooked health professionals who can make a difference in improving healthcare delivery.

Pharmacists contribute to disease prevention, including through vaccination, early detection, symptoms alleviation, and chronic condition management. Pharmacists also play a crucial role in informing and facilitating selfcare, making appropriate referrals, contributing to medication adherence and responsible use of medicines and resources.

Partnerships are crucial in ensuring the delivery of the goals of FIP in the area of NCDs management. Partners bring their specific expertise and networks to this partnership, thereby improving the quality of services and activities developed by the FIP. These partnerships yield benefits to individual members of FIP and member organisations, which ultimately benefit patients and health systems. With the increasing global focus on NCDs, the potential to partner with several organisations will be explored, in order to strengthen pharmacists’ response to this challenge.

The different organisations that collaborate or have collaborated with FIP in this area are highlighted in the various sections of this website, according to the respective disease areas.

Medical cannabis and the role of the pharmacist: a global overview

This webinar explored the evolving role of pharmacists in the dispensing of medicinal cannabis and address the increasing demand for pharmacist involvement in this emerging therapeutic area. The importance of this topic lies in the unique responsibilities pharmacists have in patient education, dispensing, monitoring and ensuring ethical standards. By addressing the pharmacological effects of cannabinoids, global regulatory frameworks and challenges for pharmacists, this event equiped pharmacists with the tools to navigate the complexities of medical cannabis use, while highlighting the need for ongoing education and training in this evolving field.

Pharmacy-based point-of-care testing: A global intelligence report – Executive summary (2024)

This publication summarises the “Pharmacy-based point-of-care testing: A global intelligence report”, a report that brings together evidence from a literature review, findings from a survey of 25 countries, 11 case studies, and the discussion of a FIP insight board, giving an overview of pharmacist-led POCT interventions around the world.POCT services, which include a wide range of tests to identify, diagnose, assess and/or monitor indicators of health, are strongly correlated with positive health outcomes. They are also linked to economic savings, increased health system efficiency and reduced burden on other healthcare sectors, the authors say. The report gives examples of POCT services being linked to prescribing authority by pharmacists, contributing to reducing pressure on general practice and emergency departments.

The role of pharmacists in the prevention and management of periodontal disease and other common oral health conditions

This event will provide pharmacists with essential knowledge about periodontal disease by exploring the basics of the disease. We will discuss the relationship between oral health and non-communicable diseases, such as diabetes, cardiovascular diseases, and kidney disease, highlighting the need for a holistic approach to wellness. Evidence-based oral hygiene recommendations tailored for effective periodontitis management will also be explored. Join us to celebrate World Oral Health Day and understand the role of pharmacists in periodontal disease and other common oral health conditions.

Iron Deficiency Anaemia: Managing symptoms and supporting selfcare. (2024)

This handbook provides pharmacists with the latest insights into iron deficiency anaemia, drawing on collective evidence and recommendations from existing guidelines and expert consensus. It addresses not only pharmacological treatment and non-pharmacological interventions but also prevention strategies. Additionally, the handbook covers guidelines for managing iron deficiency anaemia (IDA) in special populations, including paediatrics, non-pregnant women of reproductive age, pregnant women and breastfeeding mothers, the elderly, patients with chronic diseases, and individuals on strict diets. Overall, this handbook serves as an invaluable resource for pharmacists in managing IDA, underpinning the importance of pharmacists’ role in screening, managing, treating, patient education, and holistic self-care practices.

Integrating point-of-care testing in community pharmacy practice: Findings from a global intelligence report

Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework allows, a wide range of point-of-care tests (POCT) can be carried out in community pharmacies. POCT can be incorporated into disease management programmes to monitor the effects of treatment in people living with non-communicable diseases. In addition, in acute situations, pharmacy professionals can use POCT to support clinical decision-making and provide rapid, safe pharmaceutical care. These tests provide valuable data to inform health-related decisions and reduce avoidable visits to primary care physicians or emergency departments. At this event, FIP will launch a global intelligence report on pharmacy-based point-of-care testing.

 

Moderator:
– Sherif Guorgui, President of the FIP Community Pharmacy Section, Canada

Panellist:
– Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, FIP, The Netherlands
– Mfonobong Ekpoh, FIP Intern, Nigeria
– Paul Sinclair, President FIP, Australia
– Luís Lourenço, Professional secretary FIP, Portugal
– Sadaf Faisal, Director, Professional Affairs, Canadian Pharmacists Association, Canada
– Ema Paulino, President, Portuguese National Association of Pharmacies (ANF), Portugal
– Mariet Eksteen, Professional Development and Support Pharmaceutical Society of South Africa, South Africa
– Elen Jones, Director for Wales Royal Pharmaceutical Society, UK

 

Pharmacy-based point-of-care testing: A global intelligence report. (2023)

“Pharmacy-based point-of-care testing: A global intelligence report” brings together evidence from a literature review, findings from a survey of 25 countries, 11 case studies, and the discussion of a FIP insight board, giving an overview of pharmacist-led POCT interventions around the world.

POCT services, which include a wide range of tests to identify, diagnose, assess and/or monitor indicators of health, are strongly correlated with positive health outcomes. They are also linked to economic savings, increased health system efficiency and reduced burden on other healthcare sectors, the authors say. The report gives examples of POCT services being linked to prescribing authority by pharmacists, contributing to reducing pressure on general practice and emergency departments.

This document is available in:

EnglishGreek